Open-Label, Multicenter, Ph 3 Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Subjects With Non Muscle-Invasive Carcinoma in Situ and/or High-Grade Papillary Disease of the Bladder Treated With BCG. Clinical trial NCT02449239, VB4-845-02-IIIA.

Start Over

One Presidential Blvd., Suite 115 Bala Cynwyd, PA USA

Recruitment Status: Open

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Powered by